Also trades as: DTC.CN (CNQ) · $vol 0M
DTCFF OTC
Defence Therapeutics Inc.
1W: -18.9%
1M: -22.8%
3M: -7.5%
YTD: -50.2%
1Y: -45.0%
3Y: -87.1%
5Y: -94.8%
$0.28
+0.00 (+0.83%)
Weekly Expected Move ±10.8%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$3M
+76.3% ▲
Net Income
-$4M
+69.7% ▲
EPS (Diluted)
$0.00
+100.0% ▲
EBITDA
-$3M
+76.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $14K | $0 | $72K |
| Gross Profit | $0 | $0 | -$14K | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $1M | $4M | $4M | $4M | $803K |
| SG&A Expenses | $2M | $4M | $3M | $9M | $2M |
| Operating Expenses | $3M | $7M | $6M | $13M | $3M |
| Operating Income | -$3M | -$7M | -$6M | -$13M | -$3M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $263K | $0 | $323K |
| Income Before Tax | -$3M | -$7M | -$7M | -$13M | -$4M |
| Tax Expense | $0 | $0 | -$105K | $0 | $0 |
| Net Income | -$3M | -$7M | -$7M | -$13M | -$4M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.11 | $-0.20 | $-0.17 | $-0.30 | $0.00 |
| EBITDA | $0 | $0 | -$6M | -$13M | -$3M |
| Shares Outstanding | 27M | 36M | 40M | 45M | 50M |